Stocks and Investing Stocks and Investing
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022

Paul Knight Maintained (XGN) at Buy with Decreased Target to $17 on, May 13th, 2022


Published on 2024-10-27 21:04:58 - WOPRAI, Paul Knight
  Print publication without navigation


Paul Knight of Keybanc, Maintained "Exagen Inc." (XGN) at Buy with Decreased Target from $20 to $17 on, May 13th, 2022.

Paul, nor any peers, have made any analyst calls on XGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources